KADCYLA

Google image searchProduct monograph

Active ingredient

trastuzumab emtansine, 160 MG/VIAL

DIN: 02473224

Dosage form(s): POWDER FOR SOLUTION

Route(s) of administration: INTRAVENOUS

Description: SINGLE-USE VIAL

Schedule: Prescription / Schedule D

Company: HOFFMANN-LA ROCHE LIMITED

Date: 24-OCT-2018

ATC:

• L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
• L01F — MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES (ATC, ATC/DDD)
• L01FD — HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors (ATC, ATC/DDD)
• L01FD03 — TRASTUZUMAB EMTANSINE (ATC/DDD)

Reference brand drug: Kadcyla

External Links for Kadcyla

Search on Google

• Kadcyla side effects
• Kadcyla dosage
• trastuzumab emtansine side effects
• trastuzumab emtansine dosage

Hoffmann-La Roche Limited

Go to Hoffmann-La Roche website to see drug product details. Sometimes you can find kadcyla photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.